NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

BOD SCIENCE LIMITED (BOD)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 FROMTO
BOD SCIENCE LIMITED30/12/2022
BOD AUSTRALIA LIMITED18/10/202130/12/2022
BOD AUSTRALIA LIMITED18/10/2021

Shareholder links

Our website ranking of BOD: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Link Market Services Limited Sydney
Level 12, 680 George Street Sydney NSW 2000
Tel : 61 1300 554 474
Fax : 02 9287 0303
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000181331
Address: Level 2 376 New South Head Road Double Bay NSW 2028
Tel:  +61 2 9299 9690Fax: +61 2 9299 9629

Date first listed: 27/10/2016

Sector: Retailing 
Activities: Bod Australia Limited Bod is a cannabis centric global life science healthcare company With a focus and mission to innovate and transform the way we live and enjoy life Delivering premium, proven and trusted products for both the consume

News & Events

Expand this box to read and print

The half-year review by the Company's auditor Nexia Sydney Audit Pty Ltd is close to completion and the Company now expects that the Appendix 4D and Half-Year Report for the half-year ended 31st December 2023 will be lodged with the ASX by 14th June 2024.

28/05/2024

The Appendix 4D and Half-Year Report that was supposed to be lodged by 30th April 2024 is still ongoing and the Company now expects that the half-year review will be lodged by 24th May 2024.

29/04/2024

The Deed Administrator of the company announce that on 8 April 2024, creditors of BOD resolved to accept a Deed of Company Arrangement as proposed by Biortica Agrimed Limited. The DOCA was executed on 24 April 2024.

26/04/2024

The company releases the quarterly activities report.

24/04/2024

The Administrators have today issued their report to creditors and their notice to convene the second meeting of creditors which will be held on 8 April 2024.

28/03/2024

The Company was advised by ASIC on 22nd March 2024 that it had rejected the application of Bod's incumbent auditor, Nexia Sydney Audit Pty Ltd, to resign as the Company's auditor due to a perceived conflict of interest. Due to delays in receiving the ASIC decision, the Company's half-year review by Nexia Sydney Audit Pty Ltd has not yet commenced and the Company will not meet the previously advised expected lodgement date of 28th March 2024. The Company now expects that the Appendix 4D and Half-Year Report for the half-year ended 31st December 2023 will be lodged with the ASX by 30th April 2024.

25/03/2024

The Company was advised by ASIC on 22nd March 2024 that it had rejected the application of Bod's incumbent auditor, Nexia Sydney Audit Pty Ltd, to resign as the Company's auditor due to a perceived conflict of interest. Due to delays in receiving the ASIC decision, the Company's half-year review by Nexia Sydney Audit Pty Ltd has not yet commenced and the Company will not meet the previously advised expected lodgement date of 28th March 2024. The Company now expects that the Appendix 4D and Half-Year Report for the half-year ended 31st December 2023 will be lodged with the ASX by 30th April 2024.

25/03/2024

The Company's Appendix 4D and Half Year Report for the half-year ended 31st December 2023 will not be lodged by today's deadline. On 20th February 2024, Bod's auditor, Nexia Sydney Audit Pty Ltd, lodged an application with ASIC to resign as the Company's auditor due to a perceived conflict of interest. In.Corp Audit & Assurance Pty Ltd has advised the Company that it is prepared to accept the appointment as auditor to Bod and on 20th February 2024, In.Corp Audit & Assurance Pty Ltd was appointed as the Company's auditor, subject to the consent of ASIC. The Company, former auditor and new auditor are awaiting upon ASIC approval before the review for the half-year ended 31st December 2023 can commence. The ASIC form 342 was lodged with ASIC on 21st February 2024 and a response is expected within two to three weeks of that date. It is expected that the Appendix 4D and Half-Year Report for the half-year ended 31st December 2023 will be lodged with the ASX by 28th March 2024, dependent upon receiving ASIC consent within the expected timeframe.

29/02/2024

The company releases a notification of cessation of securities.

08/02/2024

The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.

30/01/2024

The Administrators of BOD Science Limited announce that on 14 December 2023, the Federal Court of Australia granted an extension of the period by which the Administrators must convene the second meeting of creditors to no later than 29 March 2024.

15/12/2023

Supply agreement with licenced cultivator, importer and genetic holder of medicinal cannabis, Green Farmers Pty Ltd (Licence Number MC022/18v3) (Green Farmers). Green Farmers is a leading Australian grower of medicinal cannabis, with a cropping facility (glasshouse) of 4,000 sqm of cultivation area.

13/12/2023

The Company releases a letter to its shareholders regarding the appointment of Administrators. The appointment was made by the Company's directors, who took the step to appoint the Voluntary Administrators to enable them, as experienced and independent parties, to assess the Company's options as to how to secure and sustain the future viability of the business. The Voluntary Administrators are presently considering opportunities to obtain funding from interested parties and/or sell the business. In the meantime, it is business as usual, as far as possible, for the Company in the short term.

01/12/2023

On 29 November 2023, the Board of Directors of Bod Science Limited the Board of Directors of Bod Science Limited of Rodgers Reidy as Joint and Several Administrators of the Company pursuant to section 436A of the Corporations Act 2001.

29/11/2023

The securities of BOD Science Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of BOD, pending the release of an announcement regarding a potential corporate transaction critical to its continued financial viability.

28/11/2023

The suspension of trading in the securities of BOD Science Limited will be lifted immediately following the release by BOD of an announcement regarding its capital raising.

08/11/2023

Bod Science has received firm commitments to raise a total of A$2.05 million under a two-tranche placement at an offer price of $0.03 per share. Bod's partner for Malaysia, Antah Healthcare, cornered the raising and will emerge as a 14.9% shareholder. Proceeds will be utilised to fund to fund inventory build, product manufacture, R&D activity to support Aqua Phase and working capital. Post transaction the Company's pro forma cash balance (as at 30 September 2023) will be $2.165m. Cash management initiatives including reduced executive salaries and director fees to be taken in shares (subject to shareholder approval).

08/11/2023

The extension to the voluntary suspension is required to enable the Company to finalise its capital raising in an orderly manner. The Company expects the voluntary suspension to last for an additional two trading days. The Company requests that the voluntary suspension remain in place until the earlier of such time as it makes an announcement to the market in relation to the outcome of the capital raising and the commencement of trading on Wednesday, 8 November 2023.

06/11/2023

The securities of BOD Science Limited were suspended from quotation under Listing Rule 17.5 on Wednesday, 1 November 2023 as BOD did not lodge its Full Year Statutory Accounts by the due date. BOD has since lodged its Full Year Statutory Accounts, however BOD will continue to be suspended from quotation under Listing Rule 17.2, at the request of BOD, pending the release of an announcement regarding its capital raising.

02/11/2023

The securities of the company will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Wednesday, 1 November 2023, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Tuesday, 31 October 2023, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed.

01/11/2023

name changed from Bod Australia Limited

30/12/2022

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    09/03/2023David Baker764,705$0.063$47,794
    16/10/2020George Livery-20,202$0.545$11,010
    20/11/2019Mark Masterson441,176$0.340$150,000
    04/11/2019George Livery20,202$0.370$7,475
    16/01/2019Joanne Patterson100,000$0.500$50,000

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    David BakerNon Exec Chairman04/04/2022
    Adrian SturrockCFO02/08/2021
    Akash BediNon Exec Director23/07/2019
    George LiveryNon Exec Director01/09/2018
    Joanne PattersonDirector, CEO27/10/2016
    Carlie HodgesCompany Secretary

    Date of first appointment, title may have changed.

    SPECIAL NOTE: During May 2024 we are working to remove duplications in the Company Secretary role.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Hanno CapponNon Exec Director21/07/202109/11/2022
    Mark MastersonNon Exec Chairman11/11/201916/05/2022
    Simon O'LoughlinNon Exec Director27/10/201604/04/2022
    Alan DworkinCFO03/05/202102/08/2021
    Patrice MalardNon Exec Director23/07/201921/07/2021
    Charles AltshulerCFO19/02/201931/03/2021
    Stephen ThompsonAlternate Director01/09/201818/12/2019
    Simon TaylorNon Exec Director27/10/201613/11/2019
    Mickey PerretNon Exec Director07/08/201721/01/2019

    Date of first appointment, title may have changed.